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Background: A heterogeneous platelet reactivity
response to clopidogrel exists, and the clinical or bio-
chemical predictors of suboptimal response to clopido-
grel remain unclear.
Objectives: The goal of this study was to identify fac-
tors associated with higher platelet aggregation following
clopidogrel therapy in subjects with acute coronary syn-
drome (ACS).
Methods: This study was conducted on 62 subjects
with ACS requiring treatment with clopidogrel (75 mg
daily for 7 days or more). The subjects were divided into
diabetic and non diabetic groups. Chrono-log Aggergom-
eter Series 490 used to estimate platelet aggregation. Fac-
tors associated with lower response to clopidogrel were
identified.
Results: A heterogeneous, normally distributed
platelet aggregation (mean 38.58 ± 18.6%) was observed
in 62 subjects (age 56.13 ± 7.9 years; 66.1% men). Statisti-
cal analysis revealed significant increased platelet aggre-
gation in patients with history of coronary artery disease
(CAD) (44.17 ± 16.3 vs 31.33 ± 19.17, p = 0.006), hyperten-
sion (44.47 ± 18.79 vs 31.43 ± 15.91, p = 0.005) and body
mass index (BMI) P 5 kg/m2 (42.54 ± 17.6 vs
27.19 ± 17.04, p = 0.004). Diabetic patients demonstrated
a trend to lower response to clopidogrel treatment with
platelet aggregation (42.87 ± 18.54) compared to non dia-
betic patients (34.29 ± 17.93) but this did not reach a sta-
tistical significance (p = 0.069). Positive correlations were
found between platelet aggregation % and the level of
fasting blood sugar (P < 0.001), body weight (p = 0.023)
and BMI (P = 0.005).
Conclusions: Hypertension, past history of CAD,
BMIP25 kg/m2 and diabetes mellitus are associated with
higher platelet aggregation following clopidogrel treat-
ment in patients with ACS. Positive correlations were
found between platelet aggregation and the level of fast-
ing blood sugar, body weight and BMI in those patients.
http://dx.doi:10.1016/j.jsha.2013.03.086
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Objectives: To define the effect of obesity in Egyp-
tian children on cardiac function and dimensions also
to investigate the possible relation between obesity and
other co-morbid cardiovascular risk factors.
Methods: Prospective descriptive study conducted
over 15 months and included 44 children with xogenous
obesity aged from 4 to 16 years with a mean of
8.54 ± 2.4 years in addition to a healthy normal weight,
matched age and sex 35 children as a control group. All
study groups underwent clinical examination, lipid pro-
file in addition to meticulous echocardiography study.
Results: Blood pressure was comparable in both
groups and mean serum triglyceride level (though in
the normal range) was significantly higher in the obese
group with P = 0.035. left ventricular wall thickness, mass
and mass index were significantly higher in obese group
compared to normal weight group with P value 0.001,
0.045 and 0.035 respectively. Myocardial diastolic func-
tion presented by isovolumetric relaxation time and E/
A was significantly different in favor for the control
group. However by correlating cardiac dimension with
the lipid profile no significant relation could be elicited.
Conclusions: Obesity in the absence of dyslipidemia
and hypertension (as co-morbid cardiovascular risk fac-
tors) is associated with increased left ventricular wall
thickness and mass also it is a risk factor for left ventricle
diastolic dysfunction.
http://dx.doi:10.1016/j.jsha.2013.03.087
The fate of the neoaortic valve and root following
the modified Ross-Konno
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Objectives: In children with aortic valve disease
associated with annular hypoplasia or complex multi-
level left ventricular outflow tract obstruction (LVOTO),
the Ross procedure, combined with a modified Konno-
type aortoventriculoplasty is advocated. We aim to
examine the fate of the neoaortic apparatus and assess
neoaortic valve function following the modified Ross-
Konno procedure.
Methods: Forty-three patients, median age 6 years,
underwent modified Ross- Konno with myectomy but
without ventricular septal patch utilization. Serial post-
operative echocardiograms (n = 187) were analyzed and
regression models adjusted for repeated measures were
used to model longitudinal growth of neoaortic annulus
and root.
Results: There were 2 operative deaths (5%) and 1
late mortality. At 8 years, survival was 93% and freedom
from autograft, homograft and all-cause reoperation was
100%, 81%, and 72%, respectively. Median post-proce-
dure diameter and Z-score were 14 mm (7–21 mm), and
1.25 (3 to +6.1) for neoaortic annulus and 21 mm (9–
30 mm) and 1.55 (1.3 to +4.1) for neoaortic root. Serial
echocardiograms showed progressive increase in annular
(+0.56 mm/year, p < 0.001) and root (+0.89 mm/year,
p < 0.001) diameters but little change in annular (0.07/
year, p = 0.08) and root (0.002/year, p = 0.96) Z-scores.
Nine patients developed autograft regurgitation, how-
ever the degree and progression of regurgitation were
not significant (p = 0.22).
Conclusions: In children undergoing the modified
Ross-Konno procedure, the neoaortic annulus and root
increase in size proportionately to somatic growth. Few
patients developed autograft regurgitation, usually mild
and stable, and none required autograft reoperation.
Our findings support the use of modified Ross-Konno
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